|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 345 Park Blvd |
Address2 |
|
| City | Itasca |
State | IL |
Zip Code | 60143 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
|
5. Senate ID# 1397-12
|
||||||||
|
6. House ID# 321820000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: James Baumberger |
Date | 5/14/2024 9:53:15 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Standards in ORR Custody ORR, HHS; Licensure of ORR Shelters ORR, HHS; Public Charge; Child Nutrition Reauthorization/WIC USDA; SNAP/Farm Bill USDA; Mental Health for Children HRSA; H.R. 6, DREAM Act; Medical Nutrition Equity Act; Lift the Bar Act (H.R. 4170/S. 2038);
PAHPA Reauthorization; CARE for Families Act HR 3107; WIC Act (S. 1604/H.R. 3364); MODERN WIC Act (S. 984/H.R. 2424)
Child passenger safety; Appropriations for the Indian Health Service HIS; Appropriations for Environmental Programs (including EPA) EPA; Maternal, Infant, and Early Childhood Home Visiting Program Reauthorization & Implementation HRSA, CMS, HHS, ACF; Infant sleep product safety CPSC; Lead exposure prevention EPA, CDC; Food safety FDA; Paid family and medical leave; Regulation of high-powered magnet sets CPSC; Climate change, Inflation Reduction Act Implementation EPA; Vehicle emissions standards EPA, NHTSA ; Button battery ingestions CPSC; Early childhood education HHS; Child product safety and injury prevention CPSC; Furniture tip-overs CPSC; Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization; CAPTA Plans of safe care grants ACF, HHS ASPE; Family First Prevention Services Act implementation ACF; CAPTA Fatalities Prevention and Response HHS; Title IV-B Reauthorization ACF; Congregate care reform HHS, ACF; Mental health supports for foster youth/former foster youth HHS; Mercury and Air Toxics Standards, ozone and particulate matter NAAQS, EPA greenhouse gas regulation EPA; QRTP/IMDs (including H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023) ACF; Firearm Violence Prevention (Including Research Funding; Background Checks); WH Domestic Policy Council; CDC; NIH; DOJ; Pregnant Workers Fairness Act Implementation EEOC; Childcare Funding & Resources HHS; Native American Child Health DOI; EPA
Strengthening Efforts to End Violence Against Children Act (H.R. 4798); PEPFAR Reauthorization; MINDS Act (H.R. 1570/S. 767); Implementation of the Global Child Thrive Act; FY24 Appropriations - SFOPS bill focused on specifically on global child health subaccounts at USAID (Vulnerable Children, Nutrition, Maternal and Child Health, and PEPFAR); FY25 Appropriations - SFOPS bill focused specifically on global child health subaccounts at USAID (Vulnerable Children, Nutrition, HIV/AIDS, Maternal and Child Health (including Gavi), WASH, PEPFAR), Department of State Child Protection Compacts, Efforts to end Child Marriage, IDA, MRA; FY24 Appropriations - LHHS bill focused specifically on CDCs global health account (Global Immunization Division), Violence Against Children Surveys, Bureau of International Labor Affairs; FY25 Appropriations - LHHS bill focused on CDCs global health account, Violence Against Children Surveys, Bureau of International Labor Affairs; USAID Advancing Protection and Care for Children in Adversity Strategy 2024-2028
Kids Online Safety Act (S. 1409/H.R. 7891); Children and Teens Online Privacy Protection Act (S. 1418/H.R. 7890); Legislation to Protect Young People Online; Pediatric Subspecialty Loan Repayment Program Funding and Program Implementation Health Resources and Services Administration; Adolescent Health Issues Department of Health and Human Services Office of the Assistant Secretary for Health; Regulation of Tobacco Products (including Proposed Menthol Cigarette and Flavored Cigar Prohibition); Food and Drug Administration; Innovation in Pediatric Drugs Act (H.R. 6664)
Continuous Eligibility for Children in Medicaid and CHIP HHS/CMS; Medicaid Payment Parity HHS/CMS; The Kids Access to Primary Care Act (HR 952); Access to Care in Medicaid/CHIP HHS/CMS; Postpartum Medicaid Extension and Maternal Health Improvements; Medicaid/CHIP Eligibility Redeterminations HHS/CMS; Ex Parte Medicaid Unwinding Issues HHS/CMS; Medicaid for Every Child Act (S. 2816);
QRTP/IMDs (including H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023, and S. 3196 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023); Accelerating Kids Access to Care Act (HR 4758, S 2372); Childrens oral health; Medicaid Early and Periodic Screening, Diagnostic, and Treatment benefit HHS/CMS; Medicaid payment for family caregivers HHS/CMS; Vaccines for Children program improvements HHS/CMS, CDC
FY25 Labor, Health and Human Services, and Education Appropriations Bill: Pediatric Subspecialty Loan Repayment Program, Firearm Injury and Mortality Prevention Research, Pediatric Mental Health Care Access Program, Emergency Medical Services for Children, National Center for Birth Defects and Developmental Disabilities, Global Immunization, Sudden Unexpected Infant Death and Sudden Death in Childhood, Vaccine Injury Compensation Program, VACCINES Act, Antimicrobial Resistance, Maternal and Child Health, School Based Health Centers, Healthy Start, Section 317 Immunization Grants; FY25 Agriculture, Rural Development, Food and Drug Administration Appropriations Bill: Pediatric Device Consortia; Newborn Screening Saves Lives Reauthorization Act; FY25 National Defense Authorization Act; Department of Defense / Defense Health Agency; Defense Health Agency - Autism Care Demonstration; Department of Defense / Defense Health Agency; Defense Health Agency - Fluoride varnish; Department of Defense/Defense Health Agency; Improving the Health of Children Act; Strengthening the Vaccines for Children Program Act; Banning Electronic Stimulation Devices FDA; SSI Savings Penalty Elimination Act (S.2767/H.R.5408); HCBS Access Act (S.762/H.R. 1493); Better Care Better Jobs Act (S.100/H.R. 547); Autism Family Caregivers Act; PREVENT HPV Cancers Act (H.R. 3633); Supplemental Security Income Equality Act (H.R. 256); IDEA Full Funding Act (S.2217/H.R.4519); Promoting Physical Activity for Americans Act (S.397); COVID-19 Commercialization CDC, HHS; Pandemic and All Hazards Preparedness Act (PAHPA); PREEMIE Reauthorization Act (H.R. 3226/S. 1573); Autism CARES Reauthorization Act; Supplemental Security Income/Social Security; Social Security Administration; School Access to Naloxone Act (H.R. 3065); HEADs UP Act (H.R. 3380); Preventing Maternal Deaths Reauthorization Act of 2023 (S. 2415/H.R.3838); Youth Sports Facilities Act; SHINE for Autumn Act (H.R.5012/S.2647); Artificial Intelligence; Congenital Heart Futures Reauthorization Act (S.3757); HERO Act (H.R. 6251); SSI Restoration Act (H.R. 7138); NURSE Act (S. 3953/H.R. 3197); Vaccines for Children coverage of Nirsevimab CDC, HHS
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Agriculture - Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA), U.S. Agency for International Development (USAID), Defense - Dept of (DOD), White House Office, Office of Science & Technology Policy (OSTP), Federal Trade Commission (FTC), Office of Management & Budget (OMB), Natl Highway Traffic Safety Administration (NHTSA), Justice - Dept of (DOJ), State - Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Johnson |
|
|
|
Zachary |
Laris |
|
|
|
Namrata |
Pujara |
|
|
|
Mandy |
Slutsker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |